CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

CAR-T Cell Therapy May Confer Responses in Relapsed/Refractory CLL or SLL, Preliminary Data Shows

February 1st 2023, 2:00pm

Article

The TRANSCNED CLL 004 trial met its primary endpoint of complete responses with the CAR-T cell therapy Breyanzi in patients with relapsed or refractory CLL or SLL.

Brukinsa Offers Better Response and Less Toxicity for CLL and SLL Treatment, But a Cure Is Still Needed

January 30th 2023, 8:00pm

Article

Two experts explain what patients need to know about the recent approval of Brukinsa for patients with chronic lymphocytic leukemia and small lymphocytic leukemia.

FDA Approves Brukinsa for Two Leukemia Types

January 19th 2023, 10:22pm

Article

The Food and Drug Administration approved Brukinsa for patients with chronic lymphocytic leukemia or small lymphocytic leukemia.

At the Start of 2023, I’m Reflecting on My New Normal With Cancer

January 11th 2023, 6:00pm

Article

Life looks a bit different after my cancer diagnosis and the COVID-19 pandemic, making me even more grateful for the people in my life.

Living Life Between Cancer Appointments

December 26th 2022, 10:00pm

Article

When cancer entered our life, fear was a constant. However, we tried to live as joyously as possible between check-ups.

Survival and Treatment Response May Be Further Improved With Brukinsa Versus Imbruvica for CLL/SLL

December 14th 2022, 8:00pm

Article

Progression-free survival and overall response rates greatly improved in patients with CLL/SLL treated with Brukinsa compared with Imbruvica.

Calquence Tends to Be a Shorter-Lived Frontline Regimen Than Imbruvica for Leukemia Subtype

December 13th 2022, 10:00pm

Article

Patients with chronic lymphocytic leukemia tended to switch to another regimen or intensify their Calquence treatment quicker than those given Imbruvica, study results showed.

Switching to Subcutaneous Medication for My Cancer-Induced Compromised Immune System Was Life Changing

December 9th 2022, 6:00pm

Article

Once I got the hang of administering subcutaneous immunoglobulin, my life was so much easier, as I no longer had to undergo monthly IV infusions for my cancer-related compromised immune system.

When It Comes to Cancer, Are We What We Eat?

November 16th 2022, 6:00pm

Article

After being diagnosed with cancer 13 years ago, I began to wonder if my diet had anything to do with it — so I made some changes to eat better.

Can Baking Bread Be Cancer Therapy?

November 1st 2022, 9:00pm

Article

I made a point to continue baking a weekly challah bread after I was diagnosed with blood cancer, and it proved to be therapeutic.